anti-CD19 CAR-T cells Clinical Trials
3 recruitingBiologic
Phase 13
Showing 1–3 of 3 trials
Recruiting
Phase 1
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Diffuse Large B Cell LymphomaNon-Hodgkin LymphomaMantle Cell Lymphoma+7 more
C. Babis Andreadis36 enrolled1 locationNCT04545762
Recruiting
Phase 1
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
Systemic Sclerosis (SSc)
The Children's Hospital of Zhejiang University School of Medicine12 enrolled2 locationsNCT06792344
Recruiting
Phase 1
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS
CAR-T Cell TherapyMulti-Drug Resistant Nephrotic Syndrome
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT06842589